We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+23.15%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$27.2B
AUM Growth
+$4.48B
(+20%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
7.53%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
3,928
New
1,420
Increased
825
Reduced
534
Closed
1,145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$599M |
| 2 |
NVIDIA
NVDA
|
+$586M |
| 3 |
Microsoft
MSFT
|
+$285M |
| 4 |
Amphenol
APH
|
+$191M |
| 5 |
Johnson & Johnson
JNJ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$727M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$441M |
| 3 |
Palantir
PLTR
|
+$307M |
| 4 |
Thomson Reuters
TRI
|
+$279M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.7% |
| 2 | Financials | 7% |
| 3 | Healthcare | 5.22% |
| 4 | Industrials | 4.77% |
| 5 | Consumer Discretionary | 4.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Metalpha Technology Holding
MATH
$42.1M
| $38K | ﹤0.01% |
+10,458
| New | +$34.5K |
|
2627
Nano X Imaging
NNOX
$73.8M
| $38K | ﹤0.01% |
+10,391
| New | +$46.3K |
|
|
TGHL
2628
The GrowHub Ltd
TGHL
$20.7M
| $38K | ﹤0.01% |
+22,731
| New | +$53.5K |
|
|
NXDT
2629
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $37K | ﹤0.01% |
+10,100
| New | +$43K |
|
2630
TTEC Holdings
TTEC
$124M
| $37K | ﹤0.01% |
+11,176
| New | +$45.8K |
|
2631
Austin Gold Corp
AUST
$16.3M
| $36K | ﹤0.01% |
+21,004
| New | +$31.3K |
|
2632
Brilliant Earth
BRLT
$21.6M
| $36K | ﹤0.01% |
+17,802
| New | +$35.9K |
|
2633
Beyond Meat
BYND
$277M
| $36K | ﹤0.01% |
+19,413
| New | +$57.2K |
|
2634
Virax Biolabs
VRAX
$2.38M
| $36K | ﹤0.01% |
+2,403
| New | +$45.8K |
|
|
RIME
2635
Algorhythm Holdings
RIME
$6.57M
| $36K | ﹤0.01% |
+13,777
| New | +$32.1K |
|
|
GORV
2636
DELISTED
Lazydays
GORV
| $35K | ﹤0.01% |
+17,270
| New | +$76.8K |
|
|
HCHL
2637
Happy City Holdings
HCHL
| $35K | ﹤0.01% |
10,692
-30,257
| -74% | -$113K |
|
2638
Bionano Genomics
BNGO
$13.3M
| $34K | ﹤0.01% |
+20,330
| New | +$64.6K |
|
2639
Gain Therapeutics
GANX
$77.6M
| $34K | ﹤0.01% |
+19,717
| New | +$33.3K |
|
2640
Pyxis Oncology
PYXS
$236M
| $34K | ﹤0.01% |
15,398
-35,270
| -70% | -$50.8K |
|
2641
Recon Technology
RCON
$3.22M
| $34K | ﹤0.01% |
+17,421
| New | +$42.3K |
|
2642
Mammoth Energy Services
TUSK
$163M
| $34K | ﹤0.01% |
+15,076
| New | +$37.1K |
|
|
IRD
2643
Opus Genetics
IRD
$302M
| $34K | ﹤0.01% |
+20,677
| New | +$25.7K |
|
2644
Celularity
CELU
$20.3M
| $33K | ﹤0.01% |
+16,062
| New | +$45K |
|
|
FURY
2645
Fury Gold Mines
FURY
$114M
| $33K | ﹤0.01% |
+51,110
| New | +$28.9K |
|
2646
Health Catalyst
HCAT
$128M
| $33K | ﹤0.01% |
+11,670
| New | +$39.9K |
|
2647
Performance Shipping
PSHG
$21.8M
| $33K | ﹤0.01% |
+17,774
| New | +$32.8K |
|
2648
Metagenomi Therapeutics
MGX
$46.3M
| $33K | ﹤0.01% |
14,097
-44,946
| -76% | -$91.2K |
|
2649
HWH International
HWH
$11.5M
| $32K | ﹤0.01% |
+11,679
| New | +$24.7K |
|
2650
PetMed Express
PETS
$42.3M
| $32K | ﹤0.01% |
+12,800
| New | +$39.6K |
|
Similar funds
DB
HRT Financial's Q3 2025 Portfolio in Review
As of Q3 2025, HRT Financial held 3,928 positions worth $27.2B, up 20% from $22.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
HRT Financial deployed $2.05B of net new capital in Q3 2025, opening 1,420 new positions and adding to 825 existing holdings. Its largest new stake was NVIDIA: 3,361,930 shares worth $627M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 6.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $441M trimmed.
- HRT Financial's largest Q3 2025 buy was NVIDIA: 3,361,930 shares worth $627M.
- HRT Financial added most to Apple in Q3 2025, an estimated $599M increase.
- HRT Financial's biggest Q3 2025 reduction was Invesco QQQ Trust, cutting an estimated $441M.
- HRT Financial fully exited Applovin in Q3 2025, selling an estimated $727M.
- HRT Financial's ten largest holdings make up 39% of its $27.2B portfolio in Q3 2025.
- HRT Financial opened 1,420 new positions and closed 1,145 in Q3 2025.
- HRT Financial's portfolio value rose 20% quarter-over-quarter to $27.2B.
Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.